Secondary antibody deficiency syndrome in haemoblastosis.
D000361:Agammaglobulinemia / Q000209:etiology*; D000906:Antibodies / Q000032:analysis; D000942:Antigens, Bacterial; D001796:Blood Protein Disorders / Q000276:immunology; D001798:Blood Proteins / Q000032:analysis; D002066:Busulfan / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D004590:Electrophoresis, Paper; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007070:Immunoglobulin A / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D007165:Immunosuppression Therapy; D007938:Leukemia / Q000150:complications* / Q000276:immunology / Q000532:radiotherapy; D007945:Leukemia, Lymphoid / Q000276:immunology; D007951:Leukemia, Myeloid / Q000276:immunology; D008357:Mannomustine / Q000627:therapeutic use; D008558:Melphalan / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000276:immunology; D011830:Radiation Effects; D012463:Saliva / Q000276:immunology; D012882:Skin Tests; D013154:Spleen / Q000528:radiation effects; D013997:Time Factors
D000906:Antibodies; D000942:Antigens, Bacterial; D001798:Blood Proteins; D007070:Immunoglobulin A; D007136:Immunoglobulins; D002699:Chlorambucil; D008357:Mannomustine; D002066:Busulfan; D008558:Melphalan